Equity Scheme - ELSS
UTI - Long Term Advantage Fund Series IV
Regular plan · IDCW · UTI Mutual Fund
Risk: High Risk
₹15.7183
NAV as of 24 Sept 2021
+0.22% day change
Other Plans of This Fund
ISININF789FC1FB1
Scheme Code140043
StructureClose Ended Schemes
Fund HouseUTI Asset Mgmt. Co. Ltd.
AUM (avg. January - March 2020)₹19.07 Cr
Expense Ratio (as of 30 Oct 2020)1.43%
Min. InvestmentRs 500/- and in multiples of Rs 500/- thereafter w
Inception Date10 Oct 2016
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
NAV history isn’t available yet for this scheme.
AUM Trend (₹ Cr, quarterly average)
Portfolio
Market Cap Split
- Large Cap0.00%
- Mid Cap0.00%
- Small Cap0.00%
- Others0.00%
Top 5 Stocks0.00%
Top 10 Stocks0.00%
Top 3 Sectors0.00%
Other funds in Equity Scheme - ELSS
| Scheme | Plan | NAV |
|---|---|---|
| Aditya Birla Sun Life ELSS Tax Saver Fund | Direct Plan · GROWTH | ₹67.7700 |
| Axis ELSS- Tax Saver Fund | Direct Plan · Growth Option | ₹110.5133 |
| BANDHAN ELSS - Tax Saver Fund | Direct Plan · Growth | ₹178.9270 |
| BANK OF INDIA ELSS TAX SAVER FUND | Direct Plan · Growth | ₹191.5700 |
| BANK OF INDIA MID CAP TAX FUND SERIES 1 | Direct Plan · Growth | ₹30.5400 |
| BANK OF INDIA MID CAP TAX FUND Series 2 | Direct Plan · Growth | ₹35.4800 |
About This Scheme
Investment Objective
The investment objective of the scheme is to generate capital appreciation over a period of ten years by investing predominantly in equity and equity-related instruments of companies along with income tax benefit. However, there can be no assurance that the investment objective of the Scheme will be realized.
Official Documents
Scheme Information Document (PDF)
Scheme Summary (PDF)
Scheme Summary (XLS)
UTI Asset Mgmt. Co. Ltd. website
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.
GMP IPO Watch